Abvc Biopharma (ABVC) Capital Expenditures (2011 - 2023)
Abvc Biopharma's (ABVC) quarterly Capital Expenditures came in at -$419374.0 in Q3 2023, down 9725.29% YoY from $4357.0 in Q3 2022, and down 471306.74% on a QoQ basis from $89.0 in Q4 2022.
Abvc Biopharma (ABVC) Capital Expenditures (2011 - 2023) Analysis & Trends
Abvc Biopharma (ABVC) has 3 years of Capital Expenditures data on file, last reported at -$419374.0 in Q3 2023.
- Quarterly Capital Expenditures fell 9725.29% year-over-year to -$419374.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was -$414928.0 (down 446.66% YoY) and the FY2023 annual result came in at $21201.0, down 82.29% from the prior year.
- Capital Expenditures fell to -$419374.0 in Q3 2023, from $89.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $93220.0 in Q1 2022 to a low of -$419374.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 251.02 Mn |
| 10 | Abvc Biopharma | 24.23 Mn | 24.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -419,374.00 |
| Sep 30, 2023 | -419,374.00 |
| Dec 31, 2022 | 89.00 |
| Dec 31, 2022 | 89.00 |
| Sep 30, 2022 | 4,357.00 |
| Sep 30, 2022 | 4,357.00 |
| Jun 30, 2022 | 22,026.00 |
| Jun 30, 2022 | 22,026.00 |
| Mar 31, 2022 | 93,220.00 |
| Mar 31, 2022 | 93,220.00 |
| Dec 31, 2011 | 350.00 |
| Dec 31, 2011 | 350.00 |
| Sep 30, 2011 | -3,000.00 |
| Sep 30, 2011 | -3,000.00 |
| Jun 30, 2011 | 52,741.00 |
| Jun 30, 2011 | 52,741.00 |